Search Results - "Irving, Elaine A"

Refine Results
  1. 1

    Role of Mitogen- and Stress-Activated Kinases in Ischemic Injury by Irving, Elaine A., Bamford, Mark

    “…Protein kinase-mediated signaling cascades constitute the major route by which cells respond to their extracellular environment. Of these, three…”
    Get full text
    Journal Article Book Review
  2. 2

    Series: Pragmatic trials and real world evidence: Paper 3. Patient selection challenges and consequences by Oude Rengerink, Katrien, Kalkman, Shona, Collier, Susan, Ciaglia, Antonio, Worsley, Sally D., Lightbourne, Alison, Eckert, Laurent, Groenwold, Rolf H.H., Grobbee, Diederick E., Irving, Elaine A.

    Published in Journal of clinical epidemiology (01-09-2017)
    “…This paper addresses challenges of identifying, enrolling, and retaining participants in a trial conducted within a routine care setting. All patients who are…”
    Get full text
    Journal Article
  3. 3

    The GetReal Trial Tool: design, assess and discuss clinical drug trials in light of Real World Evidence generation by Zuidgeest, Mira G.P., Goetz, Iris, Meinecke, Anna-Katharina, Boateng, Daniel, Irving, Elaine A., van Thiel, Ghislaine J.M., Welsing, Paco M.J., Oude-Rengerink, Katrien, Grobbee, Diederick E.

    Published in Journal of clinical epidemiology (01-09-2022)
    “…Methodologies incorporating Real World Elements into clinical trial design (also called pragmatic trials) offer an attractive opportunity to assess the effect…”
    Get full text
    Journal Article
  4. 4

    Protection against Aβ-mediated rapid disruption of synaptic plasticity and memory by memantine by Klyubin, Igor, Wang, Qinwen, Reed, Miranda N, Irving, Elaine A, Upton, Neil, Hofmeister, Jacki, Cleary, James P, Anwyl, Roger, Rowan, Michael J

    Published in Neurobiology of aging (01-04-2011)
    “…Abstract Soluble amyloid-β protein (Aβ) may cause cognitive impairment in Alzheimer's disease in the absence of significant neurodegeneration. Here, the…”
    Get full text
    Journal Article
  5. 5

    Differential activation of MAPK/ERK and p38/SAPK in neurones and glia following focal cerebral ischaemia in the rat by Irving, Elaine A, Barone, Frank C, Reith, Alastair D, Hadingham, Sarah J, Parsons, Andrew A

    Published in Brain research. Molecular brain research. (14-04-2000)
    “…Two relatively well characterised kinase signalling pathways are those involving MAPK/ERK and p38/SAPK2, that are known to be activated in vitro by various…”
    Get full text
    Journal Article
  6. 6

    Peri-infarct depolarizations lead to loss of perfusion in ischaemic gyrencephalic cerebral cortex by Strong, Anthony J., Anderson, Peter J., Watts, Helena R., Virley, David J., Lloyd, Andrew, Irving, Elaine A., Nagafuji, Toshiaki, Ninomiya, Mitsuyoshi, Nakamura, Hajime, Dunn, Andrew K., Graf, Rudolf

    Published in Brain (London, England : 1878) (01-04-2007)
    “…In the light of accumulating evidence for the occurrence of spontaneous cortical spreading depression and peri-infarct depolarizations in the human brain…”
    Get full text
    Journal Article
  7. 7

    Programmable microchip monitoring of post-stroke pyrexia: effects of aspirin and paracetamol on temperature and infarct size in the rat by Legos, Jeffrey J, Mangoni, Arduino A, Read, Simon J, Campbell, Colin A, Irving, Elaine A, Roberts, Jenny, Barone, Frank C, Parsons, Andrew A

    Published in Journal of neuroscience methods (30-01-2002)
    “…Background: Recent studies have demonstrated spontaneous and prolonged hyperthermia following stroke in both humans and rodents. However, a full…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Time-dependent increase in Nogo-A expression after focal cerebral ischemia in marmoset monkeys by Eslamboli, Andisheh, Grundy, Robert I., Irving, Elaine A.

    Published in Neuroscience letters (13-11-2006)
    “…Nogo-A is a myelin-associated protein that has been shown to inhibit axonal sprouting after lesions to the CNS. Several studies have demonstrated that blocking…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Identification of neuroprotective properties of anti-MAG antibody: a novel approach for the treatment of stroke? by Irving, Elaine A, Vinson, Mary, Rosin, Claudia, Roberts, Jenny C, Chapman, Debra M, Facci, Laura, Virley, David J, Skaper, Stephen D, Burbidge, Stephen A, Walsh, Frank S, Hunter, A Jacqueline, Parsons, Andrew A

    “…The inhibitory activity of myelin-associated glycoprotein (MAG) on neurons is thought to contribute to the lack of regenerative capacity of the CNS after…”
    Get full text
    Journal Article Book Review
  12. 12
  13. 13

    A selective endothelin ET A receptor antagonist, SB 234551, improves cerebral perfusion following permanent focal cerebral ischemia in rats by Zhang, Yongbo, Belayev, Ludmila, Zhao, Weizhao, Irving, Elaine A., Busto, Raul, Ginsberg, Myron D.

    Published in Brain research (31-05-2005)
    “…In recent experimental studies, a selective antagonist of endothelin ET A receptors, SB 234551, improved neurological and histological outcome in both head…”
    Get full text
    Journal Article
  14. 14

    Rapid alteration of tau in oligodendrocytes after focal ischemic injury in the rat: involvement of free radicals by Irving, E A, Yatsushiro, K, McCulloch, J, Dewar, D

    “…Glial inclusions containing the microtubule-associated protein tau are present in a variety of chronic neurodegenerative conditions. We now report a rapid and…”
    Get more information
    Journal Article
  15. 15
  16. 16
  17. 17

    Participant eligibility, recruitment and retention in pragmatic trials by Oude Rengerink, Katrien, Kalkman, Shona, Collier, Susan, Ciaglia, Antonio, Worsley, Sally D, Lightbourne, Alison, Eckert, Laurent, Groenwold, Rolf H.H, Grobbee, Diederick E, Irving, Elaine A

    Published in Journal of clinical epidemiology (2017)
    “…Abstract This paper addresses challenges of identifying, enrolling and retaining participants in a in a trial conducted within a routine care setting. All…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20